Evidence map›Paper›PMID 23153530›Full record

ArticleCancer cell2012

BMP meets AML: induction of BMP signaling by a novel fusion gene promotes pediatric acute leukemia.

John D Crispino, Michelle M Le Beau

Open access · bronzeAbstract readComment
In one paragraph

Article in Cancer cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. BMP signaling in cancer stemness and differentiation.Cell regeneration (London, England) · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

John D CrispinoDivision of Hematology/Oncology, Northwestern University, University of Chicago, Chicago, IL 60637, USA. j-crispino@northwestern.edu
Michelle M Le Beau
Northwestern University · USUniversity of Chicago · US

Funding

Mechanisms of Leukemogenesis in Down SyndromeR01CA101774 · NCI · UNIVERSITY OF CHICAGO · PI CRISPINO, JOHN D · 2003 to 2021
$6.1M
NCI NIH HHS R01 CA101774
6 · The paper itself

Abstract

In this issue of Cancer Cell, Gruber et al. report that a significant proportion of children with acute megakaryoblastic leukemia acquire a translocation that confers enhanced BMP signaling and promotes self-renewal of hematopoietic progenitors. This study presents novel therapeutic targets that may lead to improved therapies for this aggressive leukemia.

Identifiers

PMID23153530
PMCPMC3501979
OpenAlexW2049422699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.